Clay Siegall is an innovator and a businessman who was tested and found a new way to treat not only the many harmful and deadly cancerous side effects, but also how to treat cancer itself without ever having to use harmful radiation or chemicals in the process of eliminating the cancer cells. Clay Siegall is the founder of Seattle Genetics that was founded in 1998 to offer individuals with cancerous cells in all stages a new and cheaper alternative to the treatment. Clay Siegall has proved himself to be a top leader and innovator of the company who has involved himself with all of the discoveries of the company and is the force behind the innovation that is shown through this company and the results that this company provides to the customers. Mr. Siegall has demonstrated his capability with the product and has secured almost $700 million in private as well as public investments.
In recent news, Clay Siegall was honored with a new position to be appointed to the board of directors for Mirna Therapeutics as he has shown his excellence within the business industry in addition to his excellence that has been shown in the industry of biotechnology. Dr. Siegall will be a distinguished member of the group and will act as a mentor to the board. Dr. Siegall will continue his innovative progress and will help develop Mirna Therapeutics in both the science aspect of the company as well as in the business side of the company.
Mirna is a company that, like Seattle Genetics, specializes in biotechnology and ingenuity. With some of the top experts in the oncology department involved with the creation of a great product to help with the body, Mirna is truly and innovative company that will prove to help the lives of many individuals on the way to success. The goal of these biotechnology companies is to target to cancerous cells directly without harming the good cells within the body. This means no side effects will be involved with the treatment that are often associated with radiation as well as with chemotherapy.